TransEnterix Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:$239.8M
Industry:Medical Equip
Founded:2006
Lead Investor(s):Hercules Capital Inc

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • TransEnterix's estimated annual revenue is currently $2.4M per year.
  • TransEnterix received $40.0M in venture funding in May 2018.
  • TransEnterix's estimated revenue per employee is $13,714
  • TransEnterix's total funding is $239.8M.

Employee Data

  • TransEnterix has 175 Employees.
  • TransEnterix grew their employee count by -20% last year.
  • TransEnterix currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
LINET Americas
$27.6M11020%N/A-N/A
SonaCare Medica...
$13.1M52N/AN/A-N/A
CarboFix
$16.1M6425%N/A-N/A
Attends Healthc...
$41.7M166N/AN/A-N/A
Cortech Solutio...
$3.8M15N/AN/A-N/A
Instrumentarium...
$3M12N/AN/A-N/A
SunTech Medical
$27.9M111N/AN/A-N/A
Aribex
$3.8M15N/AN/A-N/A
Tryton Medical
$4.3M17N/AN/A-N/A
Pelton & Crane ...
$39.2M156N/AN/A-N/A
Missing a competitor? Contribute!?
Submit

TransEnterix® Surgical, Inc. (NYSE:TRXC), headquartered in Morrisville, North Carolina, is advancing surgery through innovation®. Our vision is to improve clinical outcomes and patient care through the use of robotics in surgery. We are focused on the commercialization of the Senhance Surgical System. Senhance has been granted a CE Mark and is available for sale in the United States. For a complete list of indications for use, please visit: https://www.transenterix.com/indications-for-use/

keywords:N/A

175

Number of Employees

$2.4M

Revenue (est)

1

Current Jobs

-20%

Employee Growth %

$239.8M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

TransEnterix News

04/09/2019 - TransEnterix Announces Proposed Public Offering of ...

TransEnterix intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in ...

05/09/2019 - TransEnterix prices stock offering; shares down 18%

TransEnterix (TRXC -17.6%) is down on below-average volume in response to its public offering of 28M common shares that it expects to ...

04/09/2019 - TransEnterix -9.4% after filing to offer shares

TransEnterix (NYSEMKT:TRXC) is 9.4% lower postmarket after filing to offer shares of common stock. The company plans to offer $20M in ...

TransEnterix Funding

DateAmountRoundLead InvestorsReference
2009-10-08$55.0MBAisling CapitalArticle
2014-05-08$52.0MUndisclosedArticle
2014-10-01$25.0MUndisclosedOxford FinanceArticle
2015-07-14$52.0MUndisclosedStifelArticle
2016-12-22$25.0MUndisclosedLincoln Park CapitalArticle
2017-01-09$5.2MUndisclosedSOFAR S.p.AArticle
2017-05-01$UndisclosedUndisclosedStifelArticle
2018-05-25$40.0MUndisclosedHercules Capital IncArticle

TransEnterix Executive Hires

DateNameTitleReference
2015-09-01Paul ZieglerVP SalesArticle
2015-10-02Anthony FernandoManaging Director TransEnterix ItaliaArticle
2015-11-04Steven BoudrezVP Sales, EuropeArticle
2016-05-27Theodore N. PappasSenior Surgical OfficerArticle
2018-09-05Eric SmithChief Commercial OfficerArticle

TransEnterix New Location/Offices

DateLocationReference
2009-12-22Charlotte, NCArticle